Endocrinology Drugs Market by Therapy Area and Geography - Forecast and Analysis 2020-2024

Global Endocrinology Drugs Market 2020-2024
Technavio has been monitoring the global endocrinology drugs market and it is poised to grow by USD 24.78 bn during 2020-2024, progressing at a CAGR of 7% during the forecast period. Our reports on global endocrinology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by increase in incidence of endocrine disorders . In addition, association between obesity and endocrine disorders is anticipated to boost the growth of the global endocrinology drugs market as well.

Market Segmentation
Technavio’s global endocrinology drugs market is segmented as below:

Therapy area
Diabetes Drugs
Thyroid Hormone Disorder Drugs
HGH
Testosterone Replacement Therapy
Others
Geographic segmentation
North America
Europe
Asia
ROW
Key Trends for global endocrinology drugs market growth
This study identifies association between obesity and endocrine disorders as the prime reasons driving the global endocrinology drugs market growth during the next few years.

Prominent vendors in global endocrinology drugs market
We provide a detailed analysis of around 25 vendors operating in the global endocrinology drugs market, including some of the vendors such as Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, Eli Lilly and Co., GlaxoSmithKline Plc, Groupe Sanofi, Merck & Co. Inc., Novartis International AG, Novo Nordisk AS and Pfizer Inc. .

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

About Technavio
Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio’s market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.


  • Executive Summary
  • Market Landscape
    • Market ecosystem
      • Table Parent market
      • Table Market characteristics
  • Market Sizing
    • Market definition
      • Table Product / Service portfolio of key vendors included in the market definition
    • Market segment analysis
      • Table Market segments
    • Market size 2019
    • Market outlook: Forecast for 2019 - 2024
      • Table Global - Market size and forecast 2019 - 2024 ($ Billion)
      • Table Global market: Year-over-year growth 2019 - 2024 (%)
  • Five Forces Analysis
    • Table Five forces analysis 2019 & 2024
    • Bargaining power of buyers
      • Table Bargaining power of buyers
    • Bargaining power of suppliers
      • Table Bargaining power of suppliers
    • Threat of new entrants
      • Table Threat of new entrants
    • Threat of substitutes
      • Table Threat of substitutes
    • Threat of rivalry
      • Table Threat of rivalry
    • Market condition
      • Table Market condition - Five forces 2019
  • Market Segmentation by therapy area
    • Table Therapy area placement - Market share 2019-2024 (%)
    • Diabetes drugs - Market size and forecast 2019- 2024
      • Table Diabetes drugs - Market size and forecast 2019-2024 ($ Billion)
      • Table Diabetes drugs - Year-over-year growth 2019-2024 (%)
    • hGH - Market size and forecast 2019-2024
      • Table hGH - Market size and forecast 2019-2024 ($ Billion)
      • Table hGH - Year-over-year growth 2019-2024 (%)
    • Thyroid hormone disorders - Market size and forecast 2019-2024
      • Table Thyroid hormone disorders - Market size and forecast 2019-2024 ($ Billion)
      • Table Thyroid hormone disorders - Year-over-year growth 2019-2024 (%)
    • Testosterone replacement therapy - Market size and forecast 2019-2024
      • Table Testosterone replacement therapy - Market size and forecast 2019-2024 ($ Billion)
      • Table Testosterone replacement therapy - Year-over-year growth 2019-2024 (%)
    • Others - Market size and forecast 2019-2024
      • Table Others - Market size and forecast 2019-2024 ($ Billion)
      • Table Others - Year-over-year growth 2019-2024 (%)
  • Customer landscape
    • Table Customer landscape
  • Geographic Landscape
    • Geographic segmentation
      • Table Market share by geography 2019-2024 (%)
    • North America - Market size and forecast 2019- 2024
      • Table North America - Market size and forecast 2019-2024 ($ Billion)
      • Table North America - Year-over-year growth 2019-2024 (%)
    • Europe - Market size and forecast 2019-2024
      • Table Europe - Market size and forecast 2019-2024 ($ Billion)
      • Table Europe - Year-over-year growth 2019-2024 (%)
    • Asia - Market size and forecast 2019-2024
      • Table Asia - Market size and forecast 2019-2024 ($ Billion)
      • Table Asia - Year-over-year growth 2019-2024 (%)
    • ROW - Market size and forecast 2019-2024
      • Table ROW - Market size and forecast 2019-2024 ($ Billion)
      • Table ROW - Year-over-year growth 2019-2024 (%)
    • Key leading countries
      • Table Key leading countries
    • Market opportunity by geography
      • Table Market opportunity by geography ($ Billion)
  • Drivers, Challenges, and Trends
    • Market drivers
    • Market challenges
      • Table Impact of drivers
      • Table Impact of challenges
    • Market trends
  • Vendor Landscape
    • Overview
    • Vendor landscape
    • Landscape disruption
      • Table Landscape disruption
      • Table Industry risks
  • Vendor Analysis
    • Vendors covered
      • Table Vendors covered
    • Market positioning of vendors
      • Table Market positioning of vendors
    • Abbott Laboratories
      • Table Abbott Laboratories - Overview
      • Table Abbott Laboratories - Business segments
      • Table Abbott Laboratories - Key offerings
      • Table Abbott Laboratories – Key news
      • Table Abbott Laboratories - Key customers
      • Table Abbott Laboratories - Segment focus
    • AbbVie Inc.
      • Table AbbVie Inc. - Overview
      • Table AbbVie Inc. - Business segments
      • Table AbbVie Inc. - Key offerings
      • Table AbbVie Inc. - Key news
      • Table AbbVie Inc. - Key customers
      • Table AbbVie Inc. - Segment focus
    • AstraZeneca Plc
      • Table AstraZeneca Plc - Overview
      • Table AstraZeneca Plc - Product and service
      • Table AstraZeneca Plc - Key offerings
      • Table AstraZeneca Plc – Key news
      • Table AstraZeneca Plc - Key customers
      • Table AstraZeneca Plc - Segment focus
    • Eli Lilly and Co.
      • Table Eli Lilly and Co. - Overview
      • Table Eli Lilly and Co. - Business segments
      • Table Eli Lilly and Co. - Key offerings
      • Table Eli Lilly and Co. –Key news
      • Table Eli Lilly and Co. - Key customers
      • Table Eli Lilly and Co. - Segment focus
    • GlaxoSmithKline Plc
      • Table GlaxoSmithKline Plc - Overview
      • Table GlaxoSmithKline Plc - Business segments
      • Table GlaxoSmithKline Plc - Key offerings
      • Table GlaxoSmithKline Plc – Key news
      • Table GlaxoSmithKline Plc - Key customers
      • Table GlaxoSmithKline Plc - Segment focus
    • Groupe Sanofi
      • Table Groupe Sanofi - Overview
      • Table Groupe Sanofi - Business segments
      • Table Groupe Sanofi - Key offerings
      • Table Groupe Sanofi – Key news
      • Table Groupe Sanofi - Key customers
      • Table Groupe Sanofi - Segment focus
    • Merck & Co. Inc.
      • Table Merck & Co. Inc. - Overview
      • Table Merck & Co. Inc. - Business segments
      • Table Merck & Co. Inc. - Key offerings
      • Table Merck & Co. Inc. –Key news
      • Table Merck & Co. Inc. - Key customers
      • Table Merck & Co. Inc. - Segment focus
    • Novartis International AG
      • Table Novartis International AG - Overview
      • Table Novartis International AG - Business segments
      • Table Novartis International AG - Key offerings
      • Table Novartis International AG – Key news
      • Table Novartis International AG - Key customers
      • Table Novartis International AG - Segment focus
    • Novo Nordisk AS
      • Table Novo Nordisk AS - Overview
      • Table Novo Nordisk AS - Business segments
      • Table Novo Nordisk AS - Key offerings
      • Table Novo Nordisk AS – Key news
      • Table Novo Nordisk AS - Key customers
      • Table Novo Nordisk AS - Segment focus
    • Pfizer Inc.
      • Table Pfizer Inc. - Overview
      • Table Pfizer Inc. - Business segments
      • Table Pfizer Inc. - Key offerings
      • Table Pfizer Inc. –Key news
      • Table Pfizer Inc. - Key customers
      • Table Pfizer Inc. - Segment focus
  • Appendix
    • Scope of the report
    • Currency conversion rates for US$
      • Table Currency conversion rates for US$
    • Research methodology
      • Table Research Methodology
      • Table Validation techniques employed for market sizing
      • Table Information sources
    • List of abbreviations
      • Table List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook